SCHEMBL23287976

SCHEMBL23287976

Cc1ccc(NC(=O)c2cc(CC(=O)OC(C)(C)C)ccc2Cl)nc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.57
▸ LMNA P02545 1/20 0.57
▸ NPC1 O15118 7/20 0.55
▸ RAB9A P51151 7/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ MAPT P10636 1/20 0.47
▸ POLB P06746 1/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ TP53 P04637 2/20 0.45
▸ GAA P10253 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ MITF O75030 1/20 0.45
▸ RXFP1 Q9HBX9 1/20 0.44
▸ GLA P06280 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ SAE1 Q9UBE0 1/20 0.43
▸ UBA2 Q9UBT2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19651332 0.75 KDM4E (0.70) KDM4ELMNANPC1RAB9ASMN1; SMN2
SCHEMBL23288021 0.72 MRGPRX4 (0.43) KDM4ENPC1RAB9ASMN1; SMN2MAPT
SCHEMBL23288040 0.71 EGFR (0.39) —
SCHEMBL25487719 0.71 MTNR1A (0.44) SMN1; SMN2MAPTALDH1A1KMT2AMEN1
SCHEMBL7119948 0.71 SMN1; SMN2 (0.83) KDM4ELMNANPC1RAB9ASMN1; SMN2
SCHEMBL18160436 0.70 RAB9A (0.67) KDM4ELMNANPC1RAB9ASMN1; SMN2
SCHEMBL16883496 0.70 KDM4E (0.62) KDM4ELMNANPC1RAB9ASMN1; SMN2
SCHEMBL1126145 0.70 RAB9A (0.62) KDM4ENPC1RAB9ASMN1; SMN2MAPT
SCHEMBL15903693 0.70 SORT1 (0.71) KDM4ENPC1RAB9ASMN1; SMN2MAPT
SCHEMBL15903695 0.70 SORT1 (0.67) KDM4ELMNANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021080013-A1 INHIBITORS OF TREK (TWIK RELATED K+ CHANNELS) CHANNEL FUNCTION ONO PHARMACEUTICAL CO., LTD. (JP) 2021-04-29 — — WO disclosed
Send feedback